Legate Technologies

Accelerating Proven, Battle-Ready Innovation

Battlefield technology evolves in months — not years. Yet traditional defence procurement still moves at a peacetime pace. With shifting alliances and rising threats, NATO nations can no longer afford delay.

Founded by leaders in Government, military, strategy, finance, and innovation, Legate brings together decades of real-world experience to redefine how next-generation defence capability is delivered.

Legate exists to close that gap — transforming bold ideas into pre-vetted, mission-ready capabilities at speed.

Empowering Innovation at Scale

Many defence technology firms create world-class products but struggle to scale. Whether due to limited production capacity, funding constraints, or complex market entry challenges, too many promising innovations fail to reach their potential.

Strategic Partnership

Legate acquires and partners with companies developing breakthrough defence technologies, providing the capital and structure required for sustainable growth.

Access to NATO and Allied Markets

Legate operates a structured ecosystem designed to identify, assess, finance, manufacture, and commercialize innovative defense and dual-use technologies. Based in the United Kingdom, Legate invests in and accelerates proven, battle-ready products, carrying them from validated prototype to frontline deployment across NATO and allied markets.

Learn More About Legate

Mintovate Serves as Legate's U.S. Regional Hub

Legate has designated Mintovate as its U.S. Regional Hub. We are a tech scout that sources, prepares, and submits American candidates. Mintovate will take a U.S. company from the first conversation to a complete Legate application: running the readiness screen, assembling the technical and financial record, managing the compliance and expert review stages, and staying at the table through the formation of the joint venture that follows.

What Legate brings is the half no American firm can assemble alone. Capital committed to the venture itself. Manufacturing and distribution inside the EU and the United Kingdom. Legal and regulatory support in those markets. And a sales team positioned to reach allied buyers directly.

What We Do

Assess fit before you spend.

We measure your technology against Legate's threshold first, covering readiness, market, regulatory position, and ownership, so you know where you stand before any fee is due.

Build the application.

Business plan, financial model, technical record, and pitch. We prepare the material Legate's expert panel reviews, and we coach the team that presents it.

Stand up the venture.

If Legate makes an offer, we stay through the negotiation and the transition into the new company, including its first ninety days of operation.

Who is this for

Legate invests in technology that is already proven: validated prototypes and fielded products at Technology Readiness Level 8 or above, with clear ownership of the intellectual property and a team prepared to run a company in Europe. Legate purchases IP or takes an exclusive license for the EU and United Kingdom market, holds that license in a UK company, and reviews at eighteen months whether to keep operating or to sell.

The trade opens a market most American companies cannot reach on their own, and it is not the right trade for everyone. If your technology is earlier than Level 8, or licensing a market is not something you are prepared to do, explore different routes with Mintovate via Work With Us.

Legate's Simple 3-Step Process

Step 1. Application and screening.

You apply through the Legate portal under NDA. Legate confirms eligibility and fit against its readiness threshold. Mintovate prepares the submission and the record behind it.

Step 2. Review and expert report.

A secure questionnaire goes to Legate's expert panel, which reviews the technology for readiness, compliance, and market fit. Companies that pass commission a bespoke NATO and EU market report, prepared and signed by a retired military expert, alongside a Know Your Client review. Fees for both are paid to Legate and disclosed before you commit. The report is yours to keep whether or not an offer follows.

Step 3. Financing and the new Venture.

If Legate proceeds, it makes a financial offer and a UK joint venture company is formed to hold the technology for the European market. Legate invests in that company, not in your U.S. business, so you keep your equity and every other market. Your team runs the venture and can draw salaries from it. At eighteen months the board reviews sales and decides jointly whether to continue operating or to sell.

From there, the technology reaches allied government customers through Legate's own sales channel, and Mintovate stays with you throughout.

Check Your Readiness